provider portal
Wesper Journal
GLP-1 Receptor Agonists and Obstructive Sleep Apnea (OSA): A New Era in Sleep Health ManagementThe approval of GLP-1 receptor agonists, such as Zepbound (tirzepatide), represents a groundbreaking development in the treatment of Obstructive Sleep Apnea (OSA). These medications not only...
Continue reading
In a landmark move, the FDA approved Zepbound (tirzepatide), the first GLP-1-based medication for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity, offering hope beyond traditional CPAP therapy. It works by activating GLP-1 and GIP hormone...
Continue reading
Many people experience immediate mental clarity and reduced brain fog after just one night of using CPAP therapy, as it alleviates airway obstruction and enhances sleep quality. The therapy delivers consistent airway support, leading to improved oxygen levels and restorative...
Continue reading
Sleep-disordered breathing (SDB) exists on a continuum, from benign snoring to severe sleep apnea. However, a large proportion of patients fall into a subclinical zone, where breathing irregularities and intermittent hypoxia occur but fail to meet the traditional diagnostic thresholds for OSA.
Sleep apnea in your 20s, characterized by symptoms like loud snoring, excessive fatigue, and difficulty concentrating, can significantly disrupt daily life and health. Early diagnosis and exploring treatment options such as CPAP, oral appliances, and lifestyle changes, alongside leveraging healthcare...
Continue reading
